Miranda Yaver

Ahead of the final 2027 Medicare Physician Fee Schedule, guest interviewer Cameron Sabat, a medical student at Georgetown University, sat down separately with the four health policy experts that you just heard.

Dr. Michael Chernew of Harvard Medical School, a former chair of the Medicare Payment Advisory Commission or MedPAC, Dr. Jonathan Ketcham of Arizona State University, Dr. Miranda Yaver of the University of Pittsburgh, and Dr. David Meltzer of the University of Chicago.

Medical Economics Senior Editor Richard Payerton connects those interviews to cover whether the 2027 drop in the conversion factor is really a cut, what a proposed pay cut for visits on the same day as a procedure would mean for older patients, and which payment model, if any, gets it right.

And if you're listening on the morning that this episode comes out, Thursday, October 29th, there's still time to join us this afternoon for Physicians Practice Practice Academy series.

Having worked at the administration and having observed this market for a long time, The fundamental challenge comes from having politicals and careers with inside the DC Beltway setting these prices at a very micromanaging level.

And what that does is it really mutes the market signals about supply and demand in a way that I think it's virtually impossible for even the smartest people with the best data to get it right compared to what a market can do.

When do lower payments hurt patient access and health? Miranda Yaver, a professor at the University of Pittsburgh, is author of Coverage Denied, a book-length study of inequality in health care.

At what point do incremental reimbursement reductions become a patient access problem rather than simply a physician compensation problem?